Biotest AG
DUS:BIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biotest AG
DUS:BIO
|
DE |
|
Clearside Biomedical Inc
NASDAQ:CLSD
|
US |
|
V
|
VF Corp
LSE:0R30
|
US |
|
F
|
Franchetti SpA
F:D0E
|
IT |
|
A
|
Alpha Pro Tech Ltd
XMUN:APL
|
CA |
|
R
|
Rigolleau SA
BCBA:RIGO
|
AR |
|
Arcadis NV
OTC:ARCVF
|
NL |
|
Paychex Inc
NASDAQ:PAYX
|
US |
|
Maisons du Monde SA
PAR:MDM
|
FR |
|
Ashland Inc
F:AHT
|
US |
|
G
|
Greenrise Global Brands Inc
OTC:GRGBF
|
CA |
|
Pexip Holding ASA
F:4W9
|
NO |
|
A
|
Arribatec Group ASA
OSE:ARR
|
NO |
|
Yara International ASA
LSE:0O7D
|
NO |
|
S
|
Silverco Mining Ltd
OTC:SICOF
|
CA |
|
Ferrovial SA
MAD:FER
|
ES |
|
A
|
Adocia SA
PAR:ADOC
|
FR |
|
Rizzoli Corriere della Sera Mediagroup SpA
MIL:RCS
|
IT |
|
A
|
Aeon Thana Sinsap Thailand PCL
SET:AEONTS
|
TH |
|
T
|
Tesla Inc
F:TL0
|
US |
|
Medipal Holdings Corp
OTC:MEPDF
|
JP |
|
C
|
China Merchants Port Holdings Co Ltd
XMUN:CPM
|
HK |
Bankruptcy Probability
Biotest AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Biotest AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
Biotest AG
XETRA:BIO
|
795.6m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
452.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
161.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
71.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Biotest AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Biotest AG has total debt of 639.8m EUR. This includes both short-term (0 EUR) and long-term (639.8m EUR) debt.
You can find a full breakdown on its Balance Sheet.
